| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 6.001 | 15.153 | 11.016 | 2.602 | 14.321 |
| Total Income - EUR | - | - | - | - | - | 6.001 | 15.266 | 11.032 | 2.679 | 14.323 |
| Total Expenses - EUR | - | - | - | - | - | 178 | 787 | 756 | 1.113 | 13.514 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 5.823 | 14.479 | 10.276 | 1.567 | 810 |
| Net Profit/Loss - EUR | - | - | - | - | - | 5.643 | 14.020 | 9.945 | 1.316 | 680 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Ato Hema-Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 15 | 0 | 0 | 0 | 501 |
| Current Assets | - | - | - | - | - | 5.899 | 14.359 | 18.105 | 11.964 | 5.410 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 0 | 0 | 3.011 | 2.700 | 4.133 |
| Cash | - | - | - | - | - | 5.899 | 14.359 | 15.094 | 9.264 | 1.277 |
| Shareholders Funds | - | - | - | - | - | 5.684 | 14.061 | 17.966 | 11.756 | 4.941 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 230 | 299 | 139 | 208 | 970 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ato Hema-Med S.r.l.